ImmunitoAI
(IMMUNITOAI PRIVATE LIMITED)
Bengaluru
Founded in 2020
About ImmunitoAI
ImmunitoAI develops an AI-powered platform for antibody discovery and therapeutic development. The platform evaluates antibody sequences and predicts their binding strength to antigens to identify potential therapeutic candidates.
Incubators & Accelerators of ImmunitoAI
+3 more incubators
Public Links of ImmunitoAI
Frequently Asked Questions (FAQ)
Where is ImmunitoAI's headquarters?
ImmunitoAI is based out of Bengaluru.
When was ImmunitoAI founded?
ImmunitoAI was founded in the year 2020.
What is the legal name of ImmunitoAI?
The legal name of ImmunitoAI is Immunitoai Private Limited.
Who are the founders of ImmunitoAI?
ImmunitoAI is founded by Aridni Shah and Trisha Chatterjee.
Who all are Angel Investors of ImmunitoAI?
Which VC Investors & Angel Networks funded ImmunitoAI?
Which Incubators & Accelerators supported ImmunitoAI?
What are the focus areas of ImmunitoAI?
Who are ImmunitoAI's competitors?
Possible competitors of ImmunitoAI may include Acubiosys, Affigenix, Biotide Solutions and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
